Compare Definium Therapeutics Inc. Common Shares (DFTX) vs DraftKings Inc (DKNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs DraftKings Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while DraftKings Inc trades at $19.9 (market cap $9.51B). The key difference: DraftKings Inc is far larger — about 2× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, DraftKings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and DraftKings Inc for 55 Days on average.
| DFTX | DKNG | |
|---|---|---|
Market Cap | $4.71B | $9.51B |
Volume | 1,966,636 | 11,829,779 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $36.24 |
52-Week Low | $10.68 | $18.59 |
Typical Hold Time | 0 Days | 55 Days |
Enterprise Value | $3.67B | $10.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
DraftKings (DKNG) trades at $19.87, near its 52-week low, with a bearish technical outlook despite strong analyst support. The company achieved profitability in 2025 with $6.05B revenue and positive net income of $3.71M, though recent quarters show earnings misses. Operating cash flow improved to $663M in 2025, but high valuation multiples (P/E 246.33) and negative ROE (-22.12%) highlight risks. Recent news focuses on prediction market expansion and NFL season performance.
The stock faces near-term pressure from technical weakness and earnings volatility, but long-term growth drivers in sports betting and predictions remain intact. Wall Street maintains strong bullish sentiment with a $33.13 price target, though investors should weigh high valuation against execution risks and competitive threats in the evolving gaming landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About DraftKings Inc
DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.
Read more on DKNG →
